This article is sponsored by CMW Media, the premier public and media relations agency proudly serving the cannabis industry worldwide.
Medical Marijuana, Inc. has announced to its shareholders and the public that the Brazilian government has approved its hemp-derived cannabidiol (CBD) oil product, Real Scientific Hemp Oil™ (RSHO™), to be imported as a prescription medication for cancer, and is subsidizing its cost under the Brazilian federal government’s heath care system.
“We have the utmost respect for the Brazilian government that decided hemp CBD oil should be available to their people, for a variety of reasons. Medical Marijuana, Inc. is actively working with other governments to also make hemp CBD products available. We look forward to more progress on a global scale in the very near future,” states Stuart W. Titus, Ph.D. and Chief Executive Officer of Medical Marijuana, Inc.
Cancer is among the leading causes of death worldwide, with 14 million new cases and 8.2 million deaths recorded in 2014 alone according to data from the National Institutes of Health. South and Central America, along with Asia and Africa, account for 60 percent of these new cases, and 70 percent of deaths.
Real Scientific Hemp Oil™ [RSHO]™ Blue and Gold Label all-natural CBD hemp oil in oral applicator tubes ship to Brazil with government approved documentation.
Medical Uses for CBD Hemp Oil in Brazil
Until 2015, all cannabis products were illegal in Brazil, regardless of whether they were derived from drug cannabis or from hemp. In May of 2015, Medical Marijuana, Inc. made history as the first cannabis product approved by the Brazilian government for import. Its approval was due in large part to the efforts of Katiele Fischer, whose daughter Anny suffered from CDKL5 epilepsy. Fischer, who had been bringing RSHO into Brazil illegally, sued the federal government for the right to access the product. The government agreed that Fischer had the right to import the medication her daughter needed, and by the end of 2015, three conditions – epilepsy (including CDLK5), Parkinson’s disease, and chronic pain – had been approved for treatment with RSHO. Cancer joins them as the fourth approved condition.
Research has shown that the cannabinoids found naturally in cannabis can lower blood pressure, fight cancer, induce sleep, decrease seizures, relieve nausea, reduce inflammation, stimulate appetite, and far more. This bodes well for the possibility that Brazil may expand the list of qualifying indications for import of RSHO in the future. Meanwhile, the non-intoxicating oil is legal and accessible in all 50 states and more than 40 countries, where purchasers may order RSHO products online without a medical recommendation.
RSHO™ all-natural CBD hemp oil products are available in all 50 U.S. states and more than 40 countries.
The Future of CBD Hemp Oil: “Access for All”
“We are extremely proud to have created a new American export category: CBD hemp oil,” says Titus. “Our focus is ‘access for all’ and what is legally accessible to all, at this time, is hemp CBD in oil, capsules, tinctures, liquids and topicals. We envision our hemp CBD oil brands – including RSHO – becoming household names in 2016.”
Shop highly rated dispensaries near you
Showing you dispensaries nearMedical Marijuana, Inc.’s CBD hemp oil is derived from the mature stalk of the hemp plant and is considered a food nutrient delivering the benefits of cannabinoids without the psychotropic effects of THC. It contains no pesticides, herbicides, genetic modifications or heavy metals. Before becoming a finished product, it goes through multiple quality tests by top cannabis industry and food laboratories.
Titus explains, “Every country operates under different guidelines; some consider hemp CBD a product that can only be accessed with a medical prescription while others simply consider it a food product or nutritional supplement.”
In Brazil, residents who have a government-recognized medical indication and want access to RSHO hemp oil products may order them with a doctor’s prescription and approved import documentation from ANVISA. The government agency has issued a statement on its website explaining how to apply for an import certificate. HempMeds Brasil has been working for more than a year on its formal product application and regulatory submission. The company expects to continue working on the application through 2016.
About Medical Marijuana, Inc.
The mission of Medical Marijuana, Inc. (OTC Pink: MJNA) is to be the premier hemp industry innovator, leveraging its team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. It strives to create awareness within the industry and develop environmentally-friendly, economically sustainable businesses while increasing shareholder value.
For more information on Medical Marijuana, Inc. and the portfolio company brands that it promotes, please visit the company website.
About HempMeds® Brasil™
HempMeds® Brasil™ currently has three cannabis products approved for importation into Brazil as a prescription medication for epilepsy, Parkinson’s and chronic pain. The company had the first-ever cannabis product allowed for import into Brazil and its products are currently subsidized by the Brazilian government, under their health care system, for all three medical indications listed above. HempMeds Brasil™ is working on additional approvals for multiple indications, including cancer.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
LEGAL DISCLOSURE
Medical Marijuana Inc. and HempMeds® do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
